Vor Biopharma Inc (VOR)

Apr 28, 2025

Crescent Biopharma Appoints David Lubner to Board of Directors - The Manila Times

Apr 28, 2025

Apr 26, 2025

PureTech Founded Entity Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined with a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML) - The Globe and Mail

Apr 26, 2025

Apr 26, 2025

Vor Biopharma faces Nasdaq delisting over low stock price - Investing.com

Apr 26, 2025

Apr 25, 2025

Vor Biopharma faces Nasdaq delisting over low stock price By Investing.com - Investing.com Nigeria

Apr 25, 2025

Apr 23, 2025

Vor Biopharma Inc’s Market Journey: Closing Strong at 0.70, Up 2.27 - DWinneX

Apr 23, 2025

Apr 21, 2025

Vor Biopharma Inc. (NYSE:VOR) Receives Average Recommendation of “Buy” from Analysts - Defense World

Apr 21, 2025

Apr 18, 2025

Shares Of Vor Biopharma Inc (NASDAQ: VOR): Are They Overvalued Compared To Others? - Stocksregister

Apr 18, 2025

Apr 17, 2025

INVESTOR ALERT: Cohen Milstein Calls on Zenas BioPharma - GlobeNewswire

Apr 17, 2025

Apr 09, 2025

Vor Biopharma stock plunges to 52-week low of $0.5 By Investing.com - Investing.com Canada

Apr 09, 2025

Apr 09, 2025

Vor Biopharma stock plunges to 52-week low of $0.5 - Investing.com

Apr 09, 2025

Apr 03, 2025

Vor Biopharma CMO resigns to pursue new opportunity By Investing.com - Investing.com Australia

Apr 03, 2025

Apr 03, 2025

Vor Biopharma’s Chief Medical Officer Resigns - TipRanks

Apr 03, 2025

Apr 03, 2025

Vor Biopharma CMO resigns to pursue new opportunity - Investing.com

Apr 03, 2025

Apr 02, 2025

Vor Bio Advances in Clinical Trials and Secures Funding - TipRanks

Apr 02, 2025

Apr 01, 2025

Vor Biopharma stock plunges to 52-week low of $0.63 - Investing.com

Apr 01, 2025

Apr 01, 2025

Vor Biopharma stock plunges to 52-week low of $0.63 By Investing.com - Investing.com South Africa

Apr 01, 2025

Apr 01, 2025

Zenas BioPharma, Inc. Announcement: If You Have Suffered - GlobeNewswire

Apr 01, 2025

Apr 01, 2025

Virtu Financial LLC Makes New $60,000 Investment in Vor Biopharma Inc. (NYSE:VOR) - Defense World

Apr 01, 2025

Mar 31, 2025

Here's Why Vor Biopharma (NASDAQ:VOR) Must Use Its Cash Wisely - Yahoo Finance

Mar 31, 2025

Mar 27, 2025

Vor Biopharma Inc. (NYSE:VOR) Receives Average Rating of “Buy” from Analysts - Defense World

Mar 27, 2025

Mar 25, 2025

Benitec Biopharma Inc. Announces Pricing of $30 Million Common Stock Offering - GlobeNewswire

Mar 25, 2025

Mar 24, 2025

Vor Biopharma’s SWOT analysis: stock outlook amid AML treatment progress By Investing.com - Investing.com Canada

Mar 24, 2025

Mar 24, 2025

Vor Biopharma’s SWOT analysis: stock outlook amid AML treatment progress - Investing.com India

Mar 24, 2025

Mar 24, 2025

Vor Biopharma stock holds $6 target, Market Outperform rating By Investing.com - Investing.com South Africa

Mar 24, 2025

Mar 24, 2025

Vor Biopharma stock holds $6 target, Market Outperform rating - Investing.com India

Mar 24, 2025

Mar 24, 2025

Citizens JMP Reiterates Market Outperform Rating on Vor Biopharma, Inc. (VOR) - StreetInsider

Mar 24, 2025

Mar 23, 2025

Stifel Nicolaus Has Lowered Expectations for Vor Biopharma (NYSE:VOR) Stock Price - Defense World

Mar 23, 2025

Mar 23, 2025

Oppenheimer Reiterates “Outperform” Rating for Vor Biopharma (NYSE:VOR) - Defense World

Mar 23, 2025

Mar 22, 2025

Wedbush Reaffirms Outperform Rating for Vor Biopharma (NYSE:VOR) - Defense World

Mar 22, 2025

Mar 22, 2025

Stifel cuts Vor Biopharma stock target to $5, maintains Buy rating - Investing.com Canada

Mar 22, 2025

Mar 21, 2025

Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Skye Bioscience (SKYE) and Bristol-Myers Squibb (BMY) - The Globe and Mail

Mar 21, 2025

Mar 21, 2025

Stifel cuts Vor Biopharma stock target to $5, maintains Buy rating By Investing.com - Investing.com South Africa

Mar 21, 2025

Mar 21, 2025

Vor Biopharma, Inc. (VOR) PT Lowered to $5 at Stifel - StreetInsider.com

Mar 21, 2025

Mar 20, 2025

Vor Biopharma Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 20, 2025

Mar 20, 2025

Vor Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Company Update - MarketScreener

Mar 20, 2025

Mar 20, 2025

Vor Biopharma (VOR) Files $350M Mixed Shelf - StreetInsider.com

Mar 20, 2025

Mar 20, 2025

Vor Biopharma Inc. SEC 10-K Report - TradingView

Mar 20, 2025

Mar 20, 2025

Vor Biopharma Inc. (VOR) reports earnings - Quartz

Mar 20, 2025

Mar 18, 2025

Vor Biopharma revises stock option exercise prices - MSN

Mar 18, 2025

Mar 14, 2025

Vor Biopharma Inc expected to post a loss of 29 cents a shareEarnings Preview - TradingView

Mar 14, 2025

Mar 13, 2025

BenitecAnother Biopharma Rocket - Barchart

Mar 13, 2025

Mar 12, 2025

Upstream Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - GlobeNewswire

Mar 12, 2025

Mar 06, 2025

TCR Therapy Clinical Trial Pipeline Accelerates as 80+ - GlobeNewswire

Mar 06, 2025

Mar 02, 2025

Vor Biopharma Inc. (NYSE:VOR) Given Consensus Rating of “Buy” by Analysts - Defense World

Mar 02, 2025

Feb 24, 2025

Vor Biopharma: Short On Cash, Too Much Uncertainty For Now (VOR) - Seeking Alpha

Feb 24, 2025

Feb 20, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Feb 20, 2025

Feb 19, 2025

Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq - ACCESS Newswire

Feb 19, 2025

Feb 18, 2025

Vor biopharma chief medical officer sells $3,162 in stock By Investing.com - Investing.com Canada

Feb 18, 2025